Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Symptom |infection
Sentences 498
PubMedID- 23118525 Chronic infection with the hepatitis c virus (hcv) is a major cause of liver-related invalidity and mortality worldwide.
PubMedID- 20108989 Chronic infection with hepatitis c virus (hcv) is a major healthcare problem, affecting an estimated 170 million people worldwide.
PubMedID- 20424306 In avh and fhf groups, ttv showed co-infection with all a-g hepatitis cases whereas in cah and cirrhosis groups, ttv co-infection observed with hbv, hcv and hgv.
PubMedID- 23380966 Hepatitis-b virus infection predicts mortality of hiv and hepatitis c virus coinfected patients.
PubMedID- 24416131 infection with hepatitis c virus (hcv) is one of the major risk factors for the development of hcc 2.
PubMedID- 20091608 Antiviral therapy for recurrent liver graft infection with hepatitis c virus.
PubMedID- 22192700 Other viral infection, especially with hepatitis c, can be associated with necrotizing pns vasculitis .
PubMedID- 25381483 Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis c virus (hcv).
PubMedID- 26170396 Background: daclatasvir is an ns5a inhibitor approved for treatment of infection due to hepatitis c virus (hcv) genotypes (gts) 1-4.
PubMedID- 24621321 Chronic infection with hepatitis c virus (hcv) affects up to 170 million individuals worldwide 1 and may lead to progressive hepatic fibrosis and cirrhosis, with risk of liver failure and hepatocellular carcinoma.
PubMedID- 22537438 Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis c virus (hcv) have become the standard of care.
PubMedID- 23039099 Background: there has been limited study on the effect of infection with different hepatitis c virus (hcv) genotypes on the risk of hepatocellular carcinoma (hcc) in hepatitis b virus (hbv) endemic regions of asia.
PubMedID- 23897193 Membranoproliferative glomerulonephritis (gn) may be pathogenically associated with infection due to the hepatitis c virus (hcv) as many clinical cases have shown.
PubMedID- 23315914 Chronic infection with the hepatitis c virus (hcv) is a leading cause of global morbidity and mortality.
PubMedID- 26512676 Interferon (ifn) and cellular immune response evoked in rna-pattern sensing during infection with hepatitis c virus (hcv).
PubMedID- 26079399 infection with hepatitis c virus (hcv) represents one of the most common risk factors for hcc development, and cases of hcv-related complications have been rising over the last 2 decades.
PubMedID- 21384510 Re-infection with the hepatitis c virus (hcv) is an important development after liver transplantation (lt); it can lead to graft fibrosis.
PubMedID- 22412904 Additional modifying factors including gender, alcohol consumption or co-infection with hepatitis c virus are involved , .
PubMedID- 24475147 hepatitis c virus (hcv) leads to chronic infection in the majority of infected individuals due to lack, failure, or inefficiency of generated adaptive immune responses.
PubMedID- 21680513 Chronic infection with the hepatitis c virus (hcv) is associated with increased risk for hepatocellular carcinoma (hcc).
PubMedID- 20827411 Purpose: although infection with hepatitis c virus (hcv) affects 32 million individuals from southeast asia, little is known about the mode of hcv acquisition and the epidemiology of chronic hepatitis c (chc) in these individuals.
PubMedID- 25624998 Although liver resection and liver transplantation offer the chance of a cure for hcc, adequate management of co-existing infection with hepatitis c virus (hcv) is important to enable better long-term outcomes after surgery for hcv-related hcc.
PubMedID- 21741004 Background/purpose: chronic infection with the hepatitis c virus (hcv) is associated with impaired lipid metabolism.
PubMedID- 21509250 infection with the hepatitis c virus (hcv) is a worldwide problem.
PubMedID- 22355450 infection with hepatitis c virus (hcv) causes chronic disease in approximately 80% of cases, resulting in chronic inflammation and cirrhosis.
PubMedID- 20930961 His past medical history was significant for infection with hepatitis c virus, meningitis, cigarette smoking and previous intravenous drug use.
PubMedID- 26405760 infection with the hepatitis c virus (hcv) is believed to affect about 2% of the world population and represents the major cause of chronic liver disease, liver cirrhosis and hepatocellular carcinoma 1.
PubMedID- 22491449 The mechanisms of induction of liver injury during chronic infection with hepatitis c virus (hcv) are not well understood.
PubMedID- 19776079 Background: treatment for drug addiction is effective in reducing the harms of injection drug use, including infection with hiv and/or hepatitis c.
PubMedID- 22830036 Chronic infection with hepatitis c virus (hcv) is an independent risk factor for developing type 2 diabetes mellitus (dm) .
PubMedID- 21573177 infection with hepatitis c virus (hcv) is one of the leading causes of chronic hepatitis, liver cirrhosis and end-stage liver disease worldwide.
PubMedID- 23197230 The exclusion criteria were co-infection with hepatitis c virus (hcv) or human immunodeficiency virus type-1, serological markers suggestive of autoimmune disease, daily intake of alcohol >50 g, recent exposure to hepatotoxic drugs, and no stored sera available.
PubMedID- 22398573 Super-infection with genotype 4 hepatitis c virus in a patient treated for genotype 3 acute hepatitis c.
PubMedID- 26481253 Purpose: with daas still only being licensed for chronic hcv infection, the ongoing epidemic of acute hepatitis c (ahc) infection among msm highlights the need to identify factors allowing for optimal hcv treatment outcome.
PubMedID- 21609471 Injection drug users (idus) are at high risk of infection with hiv, hepatitis c (hcv) and other blood-borne pathogens transmitted by sharing syringes and other injection equipment.
PubMedID- 24925642 The aim of the present study was to measure the influence of chronic infection with viral hepatitis c (chc) genotype 1 and 4 on serum levels of activin-a, activin-b and follistatin, and to determine their correlations with viral load, liver damage, interleukin-6 (il-6) and tumour necrosis factor (tnf)-alpha.
PubMedID- 22662515 The following patients should be offered a planned elective cs: singleton breech presentation at term, after external cephalic version has failed, has been declined or is contraindicated; multiple pregnancies when the first twin is not cephalic; placenta praevia, minor or major, (close to or covering the os); hiv-positive women who are not on any antiretroviral therapy, have a high viral load or co-infection with hepatitis c irrespective of viral load; and women with primary genital herpes simplex virus infection occurring in the third trimester.
PubMedID- 26183704 infection with hepatitis c is an important contributor to mortality and morbidity among people living with hiv, primarily due to an increased risk of liver disease .
PubMedID- 20404464 infection with hepatitis c virus genotype 3--experience of a tertiary health care centre in south india.
PubMedID- 20617863 Background: the efficacy of combination therapy with peginterferon plus ribavirin to eradicate viral infection in patients with chronic hepatitis c (chc) is well established; moreover, it is able to arrest or even reverse liver fibrosis.
PubMedID- 23226039 Chronic infection with hepatitis c virus (hcv) is a major public health problem, with perhaps 180 million people infected worldwide.
PubMedID- 22200181 Tumor necrosis factor-alpha (tnf-alpha) is an important cytokine in generating an immune response against infection with hepatitis c virus (hcv).
PubMedID- 23913866 Kinetic differences in the induction of interferon stimulated genes by interferon-alpha and interleukin 28b are altered by infection with hepatitis c virus.
PubMedID- 23682439 Hiv clinical stage 3 or 4, co-infection with tuberculosis and hepatitis c infection and a cd4+ t cell count of <50 cells/microl were risk factors for ocular disease in hiv/aids patients.
PubMedID- 21861668 infection with hepatitis c virus (hcv) is a major global health issue.
PubMedID- 21954650 infection with the hepatitis c virus (hcv) leading to cirrhosis is the most common factor in the development of hcc.
PubMedID- 21970718 infection with hepatitis c virus (hcv) represents the major cause of liver disease, affecting more than 170 million individuals worldwide.
PubMedID- 22040268 Of note, prevalence of co-infection with hepatitis c virus was 63%, prevalence of isu was 50%, and 30% of patients were receiving art.

Page: 1 2 3 4 5 6 7 8 9 10